{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:34:15Z","timestamp":1716510855328},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,23]]},"DOI":"10.7759\/cureus.60939","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:16:16Z","timestamp":1716491776000},"source":"Crossref","is-referenced-by-count":0,"title":["Complex Transfusion Management in a Sickle Cell Patient With Anti-Fy3 Alloimmunization: A Case Report"],"prefix":"10.7759","author":[{"given":"Karen","family":"Claesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Heyrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"De Schouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mahieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.3390\/hemato3020024","article-title":"Sickle cell disease, a review","volume":"3","author":"Tebbi CK","year":"2022","unstructured":"Tebbi CK. Sickle cell disease, a review. Hemato. 2022, 3:341-66.","journal-title":"Hemato"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd P","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019, 14:263-92. 10.1146\/annurev-pathmechdis-012418-012838","journal-title":"Annu Rev Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01237-z","article-title":"Advances in the diagnosis and treatment of sickle cell disease","volume":"15","author":"Brandow AM","year":"2022","unstructured":"Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol. 2022, 15:20. 10.1186\/s13045-022-01237-z","journal-title":"J Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou ST","year":"2020","unstructured":"Chou ST, Alsawas M, Fasano RM, et al.. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020, 4:327-55. 10.1182\/bloodadvances.2019001143","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.270546","article-title":"Red cell transfusion and alloimmunization in sickle cell disease","volume":"106","author":"Linder GE","year":"2021","unstructured":"Linder GE, Chou ST. Red cell transfusion and alloimmunization in sickle cell disease. Haematologica. 2021, 106:1805-15. 10.3324\/haematol.2020.270546","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-833962","article-title":"Transfusion-related red blood cell alloantibodies: induction and consequences","volume":"133","author":"Tormey CA","year":"2019","unstructured":"Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood. 2019, 133:1821-30. 10.1182\/blood-2018-08-833962","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0037-1963(00)90037-4","article-title":"The Duffy protein: a malarial and chemokine receptor","volume":"37","author":"Pogo AO","year":"2000","unstructured":"Pogo AO, Chaudhuri A. The Duffy protein: a malarial and chemokine receptor. Semin Hematol. 2000, 37:122-9. 10.1016\/s0037-1963(00)90037-4","journal-title":"Semin Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01882.x","article-title":"New genotypes in Fy(a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B","volume":"108","author":"Rios M","year":"2000","unstructured":"Rios M, Chaudhuri A, Mallinson G, et al.. New genotypes in Fy(a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B. Br J Haematol. 2000, 108:448-54. 10.1046\/j.1365-2141.2000.01882.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2020-005","article-title":"An update on the Duffy blood group system","volume":"35","author":"Meny GM","year":"2019","unstructured":"Meny GM. An update on the Duffy blood group system. Immunohematology. 2019, 35:11-2. 10.21307\/immunohematology-2020-005","journal-title":"Immunohematology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-30","article-title":"High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti","volume":"12","author":"Weppelmann TA","year":"2013","unstructured":"Weppelmann TA, Carter TE, Chen Z, von Fricken ME, Victor YS, Existe A, Okech BA. High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti. Malar J. 2013, 12:30. 10.1186\/1475-2875-12-30","journal-title":"Malar J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2005.03.003","article-title":"The molecular genetics of blood group polymorphism","volume":"14","author":"Daniels G","year":"2005","unstructured":"Daniels G. The molecular genetics of blood group polymorphism. Transpl Immunol. 2005, 14:143-53. 10.1016\/j.trim.2005.03.003","journal-title":"Transpl Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2019-392","article-title":"Acute hemolytic transfusion reaction secondary to anti-Fy3","volume":"21","author":"Olteanu H","year":"2005","unstructured":"Olteanu H, Gerber D, Partridge K, et al.. Acute hemolytic transfusion reaction secondary to anti-Fy3. Immunohematology. 2005, 21:48-52. 10.21307\/immunohematology-2019-392","journal-title":"Immunohematology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07494.x","article-title":"Anti-Fy3 in sickle cell disease: a difficult transfusion problem","volume":"144","author":"Went R","year":"2009","unstructured":"Went R, Wright J, Webster R, Stamps R. Anti-Fy3 in sickle cell disease: a difficult transfusion problem. Br J Haematol. 2009, 144:621-2. 10.1111\/j.1365-2141.2008.07494.x","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0338-4535(84)80083-5","article-title":"Three examples of anti-Fy3 produced in negroes","volume":"27","author":"Kosinski KS","year":"1984","unstructured":"Kosinski KS, Molthan L, White L. Three examples of anti-Fy3 produced in negroes. Rev Fr Transfus Immunohematol. 1984, 27:619-24. 10.1016\/s0338-4535(84)80083-5","journal-title":"Rev Fr Transfus Immunohematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1971.tb01797.x","article-title":"A new antibody, anti-Fy3, in the Duffy blood group system","volume":"20","author":"Albrey JA","year":"1971","unstructured":"Albrey JA, Vincent EE, Hutchinson J, Marsh WL, Allen FH Jr, Gavin J, Sanger R. A new antibody, anti-Fy3, in the Duffy blood group system. Vox Sang. 1971, 20:29-35. 10.1111\/j.1423-0410.1971.tb01797.x","journal-title":"Vox Sang"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.253229","article-title":"Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy","volume":"106","author":"Stone EF","year":"2021","unstructured":"Stone EF, Avecilla ST, Wuest DL, et al.. Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy. Haematologica. 2021, 106:310-2. 10.3324\/haematol.2020.253229","journal-title":"Haematologica"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2019-263","article-title":"Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease","volume":"24","author":"Reyes M","year":"2008","unstructured":"Reyes M, Illoh O. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease. Immunohematology. 2008, 24:45-51. 10.21307\/immunohematology-2019-263","journal-title":"Immunohematology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24530","article-title":"Alloimmunization in sickle cell anemia in the era of extended red cell typing","volume":"60","author":"O'Suoji C","year":"2013","unstructured":"O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer. 2013, 60:1487-91. 10.1002\/pbc.24530","journal-title":"Pediatr Blood Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/ajts.ajts_115_22","article-title":"A comparison of serological phenotyping and molecular genotyping for Kell, Kidd, and Duffy antigens in multi-transfused thalassemia patients","volume":"17","author":"Sonker A","year":"2023","unstructured":"Sonker A, Dubey A, Mohan Y. A comparison of serological phenotyping and molecular genotyping for Kell, Kidd, and Duffy antigens in multi-transfused thalassemia patients. Asian J Transfus Sci. 2023, 17:53-7. 10.4103\/ajts.ajts_115_22","journal-title":"Asian J Transfus Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280632","article-title":"Alloimmunization against Fy3 is a serious threat in the era of cell therapy","volume":"107","author":"Lemaire B","year":"2022","unstructured":"Lemaire B, Abramowski SW. Alloimmunization against Fy3 is a serious threat in the era of cell therapy. Haematologica. 2022, 107:1986-7. 10.3324\/haematol.2022.280632","journal-title":"Haematologica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/248879-complex-transfusion-management-in-a-sickle-cell-patient-with-anti-fy3-alloimmunization-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:16:21Z","timestamp":1716491781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/248879-complex-transfusion-management-in-a-sickle-cell-patient-with-anti-fy3-alloimmunization-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.60939","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}